-
Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US
expresspharma
July 27, 2020
Various companies across the globe have announced similar recalls for the product after the USFDA pointed out the presence of NDMA above permissible limits.
-
MSD/Pfizer's diabetes drug Steglatro hits goal in CV outcomes trial
pharmatimes
June 22, 2020
MSD and Pfizer have unveiled data from the Phase III VERTIS CV cardiovascular (CV) outcomes trial which add further evidence on the safety of their diabetes drug Steglatro (ertugliflozin).
-
AstraZeneca’s diabetes drug Farxiga performs well in heart failure patients
pharmaceutical-technology
August 21, 2019
AstraZeneca has announced that Farxiga (dapagliflozin) met its primary endpoint in heart failure-focused Phase III DAPA-HF trial of patients with reduced ejection fraction (HFrEF).
-
Oral Novo Nordisk diabetes drug poses no more heart risk than placebo: study
expressbpd
June 14, 2019
Patients with type 2 diabetics and either heart disease who received the drug semaglutide in pill form had a combined rate of heart attack, stroke or heart-related death of 3.8 per cent compared with 4.8 per cent for placebo
-
Sanofi-Lexicon diabetes drug gets split verdict from FDA panel
pharmaceutical-technology
January 21, 2019
Sanofi and Lexicon Pharmaceuticals have received split decision from an advisory panel to the US Food and Drug Administration (FDA) on whether to recommend diabetes drug Zynquista (sotagliflozin) for approval....
-
Drugmaker Won't Put Price in TV Ads, But Patients Can Look It Up
firstwordpharma
January 09, 2019
Eli Lilly won't put the price of its prescription drugs in television ads, but as of Tuesday, the company will start airing ads touting a website that will have information about drug list prices, patient assistance programs and average patient cost for m
-
Drugmaker Won't Put Price in TV Ads, But Patients Can Look It Up
firstwordpharma
January 09, 2019
Eli Lilly won't put the price of its prescription drugs in television ads, but as of Tuesday, the company will start airing ads touting a website that will have information about drug list prices, patient assistance programs and average patient cost for m
-
AstraZeneca Pharma inks distribution pact with Abbott for diabetes drug
expressbpd
December 10, 2018
The company will promote and distribute Dapagliflozin under the brand name GLEDEPA
-
Zydus Cadila gets tentative US FDA nod for diabetes drug
expressbpd
October 15, 2018
The drug will be produced at the group’s formulations manufacturing facility at special economic zone (SEZ), Ahmedabad
-
Alembic Pharma gets US FDA nod for diabetes drug
financialexpress
September 18, 2018
The company’s product is a generic version of Takeda Pharma USA’s Kazano tablets